- Home
- / Asklepios BioPharmaceutical
Asklepios BioPharmaceutical
Total Funding
$235 M
Asklepios BioPharmaceutical Summary
Company Summary
- Overview
- Asklepios BioPharmaceutical is engaged in the development and delivery of novel protein. The company offers proprietary AAV technology, manufacturing capabilities and a robust pipeline of in-house clinical programs for clients in the medical biopharmaceutical industry.
- Type
- Private
- Status
- Active
- Founded
- 2001
- HQ
- Chapel Hill, NC, US | view all locations
- Website
- https://askbio.com/
- Cybersecurity rating
Table of Contents
Key People
Stefan Oelrich, Board Member
R. Jude Samulski, President, Chief Scientific Officer and Co-Founder, Board Member
Candace Summerford, Chief Patent Officer
LocationsView all
2 locations detected
Chapel Hill, NC HQ
United States
20 TW Alexander Dr #110RTP
Roslin, Scotland
United Kingdom
Easter Bush Campus